Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy

被引:0
作者
Daofu Feng
Meiha Leong
Ting Li
Lin Chen
Tao Li
机构
[1] General Hospital of Chinese PLA,Department of General Surgery
[2] General Hospital of Tianjin Medical University,Department of General Surgery
[3] Kiang Wu Hospital,Department of Surgery
来源
World Journal of Surgical Oncology | / 13卷
关键词
Gastric cancer; D2 lymphadenectomy; Pathological complete response; Complications; Neoadjuvant chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 164 条
[1]  
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]  
Bray F(2012)Global and regional mortalities from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2095-128
[3]  
Center MM(2006)Patterns of cancer incidence, mortalities, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137-50
[4]  
Ferlay J(2009)Is there a role for second-line chemotherapy in advanced gastric cancer? Lancet Oncol 10 903-12
[5]  
Ward E(2007)Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810-20
[6]  
Forman D(2011)Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer J Clin Oncol 29 4387-93
[7]  
Lozano R(2006)Disparities in gastric cancer chemotherapy between the East and West J Clin Oncol 24 2188-96
[8]  
Naghavi M(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20
[9]  
Foreman K(2011)Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 1715-21
[10]  
Lim S(2007)Adjuvant and neoadjuvant approaches in gastric cancer Cancer J 13 168-74